Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.68 +0.03 (+0.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Bolt Biotherapeutics (BOLT) Other Non-Current Liabilities (2020 - 2026)

Updated

Bolt Biotherapeutics' Other Non-Current Liabilities was $132,000 in Q2 2026, down 0.8% from $133,000 a year earlier and down 16.5% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

From Q4 2020 onward, Bolt Biotherapeutics has reported Other Non-Current Liabilities for 19 quarters.

  • Other Non-Current Liabilities shows a five-year compound annual growth rate of -16.7% (FY2020 to FY2025).
  • In earlier years, Other Non-Current Liabilities was $43,000 in FY2023 (+2.4%), $42,000 in FY2022 (-80.0%) and $210,000 in FY2021 (-36.2%).
  • Quarterly Other Non-Current Liabilities has moved between $42,000 (Q4 2022) and $217,000 (Q3 2021) over five years.
  • The best year-over-year quarter for Other Non-Current Liabilities over five years was Q1 2026 (growth of 19.7%); the worst was Q4 2022 (a decline of 80.0%).
  • Per Business Quant data, BOLT's Other Non-Current Liabilities in the three quarters before Q2 2026 was $158,000 (Q1 2026), $132,000 (Q4 2025) and $133,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bolt Biotherapeutics 7.09 Mn 7.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132,000.00
Mar 31, 2026 158,000.00
Dec 31, 2025 132,000.00
Sep 30, 2025 133,000.00
Jun 30, 2025 133,000.00
Mar 31, 2025 132,000.00
Dec 31, 2023 43,000.00
Sep 30, 2023 43,000.00
Jun 30, 2023 43,000.00
Mar 31, 2023 43,000.00
Dec 31, 2022 42,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 204,000.00
Dec 31, 2021 210,000.00
Sep 30, 2021 217,000.00
Jun 30, 2021 233,000.00
Mar 31, 2021 321,000.00
Dec 31, 2020 329,000.00
API Access

Bolt Biotherapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY